Eplivanserin

Known as: 4-[(1E,3Z)-3-{[2-(dimethylamino)ethoxy]imino}-3-(2-fluorophenyl)prop-1-enyl]phenol, SR46349 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-2016
01219962016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
In acute organ injuries, mitochondria are often dysfunctional, and recent research has revealed that recovery of mitochondrial… (More)
Is this relevant?
2013
2013
5-Hydroxytryptamine (5-HT)2A antagonists are promising therapeutic agents for the treatment of sleep maintenance insomnias, but… (More)
Is this relevant?
2013
2013
The objective of the present study was to examine the idea that the decrease in 50-kHz ultrasonic vocalizations elicited by… (More)
Is this relevant?
2011
2011
The serotonergic system appears crucial for (±)-3,4-methylenedioxymethamphetamine (MDMA) reinforcing properties. Current evidence… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2010
Review
2010
Benzodiazepine (BZD) and non-BZD hypnotics improve sleep induction and sleep maintenance. BZD induces a further reduction of slow… (More)
Is this relevant?
Review
2010
Review
2010
There has been a search for more effective and safe hypnotic drugs in the last decades. Zolpidem, zaleplon, zopiclone… (More)
Is this relevant?
2008
2008
Nearly one half of the adult population in the U.S. experience some symptoms of insomnia (difficulties with getting to sleep… (More)
Is this relevant?
2002
2002
Employing a two-lever, food-reinforced, Fixed Ratio 10 drug discrimination procedure, rats were trained to recognize the highly… (More)
  • figure 1
  • table 1
Is this relevant?
Highly Cited
1999
Highly Cited
1999
In the present study, the comparative mechanisms of action of phencyclidine (PCP) and amphetamine were addressed employing the… (More)
Is this relevant?
1996
1996
SR46349 is a novel, selective 5-HT2 receptor antagonist with the chemical structure {trans, 4-[(3Z)3-(2-dimethylaminoethyl… (More)
Is this relevant?